当社は、何百もの特許化合物の独創的な分析法の開発及びバリデーションを提供することで、製薬会社とのパートナーシップを築いてきました。現在当社は、非特許化合物測定法パッケージを構築しておりますので、ご要望の規格に合った測定のリクエストをお待ちしております。いくつかの化合物のための分析シートは既に出来上がっておりますので、分析シート（PDF）をご希望の場合は、青字の化合物名をクリックしてください。
現在提供されているバリデートされた非特許化合物の測定法は下記の通りです：
| compound | matrix | calibration range |
|---|---|---|
| AFMU | Human Urine | 100 - 20,000 ng/mL |
| Amlodipine | Human Plasma | 0.50 - 100 ng/mL |
| Amprenavir | Human Plasma | 10.0 - 10,000 ng/mL |
| Aprepitant | Human Plasma | 10.0 - 5,000 ng/mL |
| Armodafinil | Human Plasma | 100 - 10,000 ng/mL |
| Atazanavir/ Ritonavir | Human Plasma | 1.00 - 1,000 ng/mL |
| Carboplatin | Human Plasma Ultrafiltrate |
50.0 - 40,000 ng/mL |
| Cinacalcet | Human Plasma | 0.10 - 50.00 ng/mL |
| Ciprofloxacin/ Levofloxacin/ Moxifloxacin | Human Plasma | 10.0 - 1,000 ng/mL |
| Cytarabine/Ara-U | Human Plasma | 200 - 50,000 ng/mL |
| Darifenacin | Human Plasma | 50.0 to 10,000 pg/mL |
| Daunorubicin | Human Plasma | 0.10 - 10.0 ng/mL |
| Daunorubicin/Daunorubicinol | Rat Plasma | 10.0 - 1,000 ng/mL |
| Daunorubicin/Daunorubicinol | Dog Plasma | 10.0 - 1,000 ng/mL |
| Dextromethorphan/Dextrorphan | Human Urine | 1.00 - 500 ng/mL |
| Diclofenac | Human Plasma | 0.10 - 100 ng/mL |
| Diclofenac | Human Plasma | 10.0 to 2,000 ng/mL |
| Docetaxel | Human Plasma | 5.00 - 5,000 ng/mL |
| Donepezil | Human Plasma | 0.10 - 100 ng/mL |
| Duloxetine | Human Plasma | 0.20 - 100 ng/mL |
| Efavirenz | Human Plasma | 10.0 - 10,000 ng/mL |
| Emtracitabine | Human Plasma | 5.00 to 5,000 ng/mL |
| Eszopiclone | Human Plasma | 1.00 - 100 ng/mL |
| Famotidine | Human Plasma | 1.00 - 500 ng/mL |
| Fluconazole | Human Plasma | 100 - 10,000 ng/mL |
| 5-Fluorouracil | Human Plasma | 1.00 - 500 ng/mL |
| Fluticasone propionate/ Salmeterol | Human Plasma | 5.00 - 1,000 pg/mL 2.50 - 1,000 pg/mL |
| Formoterol | Human Plasma | 1.00 - 100 pg/mL |
| Hydromorphone | Human Plasma | 25.0 - 5,000 pg/mL |
| 9-Hydroxy Risperidone | Human Plasma | 0.10 - 100 nM |
| Ibandronate | Human Plasma | 0.10 – 50.00 ng/mL |
| Ketoconazole | Human Plasma | 50.0 - 5,000 ng/mL |
| Lenalidomide | Human Plasma | 1.00 to 1,000 ng/mL |
| Lopinavir/ Ritonavir | Human Plasma | 5.00 - 5,000 ng/mL |
| Mefenamic acid | Human Plasma | 50.0 - 5,000 ng/mL |
| Memantine | Human Plasma | 0.10 - 100 ng/mL |
| R,S-Methadone | Human Plasma | 5.00 - 1,000 ng/mL |
| Methotrexate | Human Plasma | 1.00 - 500 ng/mL |
| 1-Methyluric acid | Human Urine | 2,500 - 20,000 ng/mL |
| 1-Methylxanthine/ 1,7-Dimethyluric acid | Human Urine | 500 - 20,000 ng/mL |
| Metoprolol | Human Plasma | 0.50 - 250 ng/mL |
| Midazolam/ 1-Hydroxymidazolam | Human Plasma | 0.10 - 10.0 ng/mL |
| Midazolam, 1-Hydroxymidazolam, 4-Hydroxymidazolam |
Human Plasma | 0.10 - 50.0 ng/mL |
| Morphine/ Morphine-3-glucuronide/ Morphine-6-glucuronide | Human Plasma | 0.50 - 50.0 ng/mL 10.0 - 1,000 ng/mL 1.00 - 100 ng/mL |
| Moxifloxacin | Human Plasma | 25.0 to 5,000 ng/mL |
| Nelfinavir | Human Plasma | 1.00 - 1,000 ng/mL |
| Nicotine/Cotinine | Human Plasma | 1.00 - 500 ng/mL 2.00 - 1,000 ng/mL |
| Olanzapine | Human Plasma | 0.40 - 100 nM |
| Omeprazole/5-Hydroxyomeprazole | Human Plasma | 10.0 - 1,000 ng/mL |
| Paclitaxel | Human Plasma | 10.0 - 2,000 ng/mL |
| Pramipexole | Human Plasma | 50.0 - 5,000 pg/mL |
| Pregabalin | Human Plasma | 50.0 - 20,000 ng/mL |
| Quetiapine | Human Plasma | 0.50 - 2,000 ng/mL |
| Ramelteon | Human Plasma | 50.0 to 8,000 pg/mL |
| Rifaximin | Human Plasma | 0.10 to 10.0 ng/mL |
| Risperidone / 9-Hydroxy Risperidone | Human Plasma | 0.40 - 100 nM |
| Sertraline | Human Plasma | 10.0 - 5,000 ng/mL |
| Simvastatin/Simvastatin hydroxy acid | Human Plasma | 0.10 to 50.0 ng/mL |
| Tadalafil | Human Plasma | 1.00 - 500 ng/mL |
| Temozolomide | Human Plasma | 100 - 20,000 ng/mL |
| Tenofovir | Human Plasma | 5.00 - 5,000 ng/mL |
| Theophylline | Human Plasma | 100 - 50,000 ng/mL |
| Tramadol | Human Plasma | 5.00 - 500 ng/mL |
| Uracil | Human Plasma | 20.0 - 10,000 ng/mL |
| R-Warfarin/ S-Warfarin | Human Plasma | 10.0 - 1,000 ng/mL |
| Valsartan | Human Plasma EDTA | 50.0 to 10,000 ng/mL |
| Vardenafil | Human Plasma | 0.20 - 50.0 ng/mL |
| Voriconazole | Human Plasma | 5.00 - 5,000 ng/mL |
| List of Assays and Generics Under Development | ||
|---|---|---|
| Adefovir | Human Plasma | 0.10 - 100 ng/mL |
| Aliskiren | Human Plasma | 1.00 - 500 ng/mL |
| Atorvastatin/Lactone/o-Hydroxy/p-Hydroxy | Human Plasma | 0.10 - 100 ng/mL |
| Buproprion / Hydroxybuproprion / Ethrohydroxybupropion / threohydroxybuproprion |
Human Plasma | TBD |
| Doxorubicin/Doxorubicinol | Human Plasma | 0.50 - 500 ng/mL |
| Doxorubicin/Doxorubicinol | Human Plasma | 400 - 40,000 ng/mL |
| Entecavir | Human Plasma | 50.0 - 20,000 pg/mL |
| Naltrexone / Naltrexol | Human Plasma | TBD |
| Nifedipine | Human Plasma | 1-250 ng/mL |
| Nisoldipine | Human Plasma | 1-100 pg/mL |
Search